Get App Open
In App
Credit Cards
Open App
you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 06, 15:40
1968.20 -10.60 (-0.54%)
Volume
AVERAGE VOLUME
5-Day
13,990
10-Day
15,338
30-Day
19,402
5,634
  • Prev. Close

    1978.80

  • Open Price

    1978.30

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 06, 15:48
1971.20 -9.00 (-0.45%)
Volume
AVERAGE VOLUME
5-Day
545,093
10-Day
624,139
30-Day
685,550
346,596
  • Prev. Close

    1980.20

  • Open Price

    1954.60

  • Bid Price (Qty.)

    1971.20 (76)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Profit & Loss account of Glenmark Pharma (in Rs. Cr.) Mar 15 Mar 14 Mar 13 Mar 12 Mar 11  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 5,199.63 2,411.36 2,033.85 1,615.82 1,212.25  
Less: Excise/Sevice Tax/Other Levies 200.42 137.80 98.57 69.00 58.70  
Revenue From Operations [Net] 4,999.21 2,273.56 1,935.29 1,546.82 1,153.55  
Total Operating Revenues 5,085.60 2,300.90 1,949.30 1,564.67 1,162.94  
Other Income 84.94 67.13 116.25 55.10 71.75  
Total Revenue 5,170.54 2,368.04 2,065.55 1,619.77 1,234.69  
EXPENSES  
Cost Of Materials Consumed 1,564.03 467.89 415.75 337.67 240.49  
Purchase Of Stock-In Trade 173.95 159.97 141.09 104.95 87.16  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -69.65 -5.23 -3.67 -12.86 13.99  
Employee Benefit Expenses 662.25 395.35 303.02 246.81 174.16  
Finance Costs 30.19 30.98 43.69 60.87 85.75  
Depreciation And Amortisation Expenses 119.46 30.20 25.04 21.11 20.99  
Other Expenses 1,290.03 786.96 760.67 577.13 361.37  
Total Expenses 3,770.26 1,866.11 1,685.60 1,335.67 983.90  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 1,400.28 501.92 379.95 284.10 250.79  
Exceptional Items -168.74 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 1,231.55 501.92 379.95 284.10 250.79  
Tax Expenses-Continued Operations  
Current Tax 280.17 108.02 65.70 55.40 67.40  
Less: MAT Credit Entitlement 52.69 47.76 65.70 37.47 28.62  
Deferred Tax -3.46 7.84 4.78 0.87 -0.17  
Tax For Earlier Years 0.00 0.00 -10.93 0.00 0.00  
Total Tax Expenses 224.02 68.10 -6.15 18.80 38.62  
Profit/Loss After Tax And Before ExtraOrdinary Items 1,007.53 433.82 386.11 265.30 212.18  
Profit/Loss From Continuing Operations 1,007.53 433.82 386.11 265.30 212.18  
Profit/Loss For The Period 1,007.53 433.82 386.11 265.30 212.18  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 37.14 16.01 14.26 9.81 7.86  
Diluted EPS (Rs.) 37.13 16.00 14.25 9.80 7.85  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 359.92 33.54 31.41 20.58 9.17  
Indigenous Raw Materials 1,149.08 421.85 372.43 312.00 225.37  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 55.02 12.50 11.91 5.10 5.95  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 54.26 54.25 54.17 54.11 10.81  
Tax On Dividend 11.35 9.24 9.23 8.78 1.85  
Equity Dividend Rate (%) 200.00 200.00 200.00 200.00 40.00  
Source : Dion Global Solutions Limited

Results of Glenmark